Instruction to Authors
IJSS Journal of Surgery publishes Original Articles, Systematic Reviews, Randomized Clinical Trials, Case Series, Case Reports, Letter to The Editor and Commentary Pieces all of which are subjected to rigorous peer review. IJSS Journal of Surgery subscribes to the policies of International Committee of Medical Journal Editors (ICMJE) [www.icmje.org] and publishing ethics guidelines and criteria published by the Committee on Publication Ethics (COPE) [www.publicationethics.org].
On behalf of the team of co-authors, IJSS Journal of Surgery requires corresponding authors to complete an Author Statement, Copy Right Transfer Form & Conflicts of Interest Form before acceptance of the manuscript. Please do note that the hierarchy of authors should be the same as that of the manuscript.
In order to maintain the open access and to meet the maintenance charges the authors are charged nominal publication fees post acceptance.
Manuscript Submission Guidelines
Manuscripts (i.e. all the submission articles, including all text, tables, artwork, cover letter, copyright transfer, conflicts of interest disclosures, and any other required material) must be submitted online to IJSS Journal of Surgery through the Online Manuscript Portal http://surgeryijss.com/Authors/authorlogin or you can email the manuscript along with all required document. If assistance is required, please feel free to contact us email@example.com / firstname.lastname@example.org. Please do not post or fax your manuscripts to the Editorial Office.
Articles submitted should be in Microsoft Word document format and prepared in the simplest form possible, using Calibri, Font 12. Please do not use automatic page numbering, footnotes, endnotes, headers and footers.
Put text, references, and table/figure legends in one file (Word Document)
The following documents must be included:
- Ethics Statement.Articles covering human or animal experiments must be accompanied by a letter of approval from the relevant review committee or authorities.
- Consolidated Standards of Reporting Trials (CONSORT) flow chart for randomized controlled trials submitted for publication. [LINK]
- Articles where human subjects can be identified in descriptions, photographs or pedigrees must be accompanied by a signed statement of informed consent to publish (in print and online) the descriptions, photographs and pedigrees from each subject who can be identified.
- Copyright Permission. If you have reproduced or adapted material from other copyrighted sources, the letter(s) of permission from the copyright holder(s) to reproduce or adapt the copyrighted sources must be supplied. Otherwise, such material must be removed from your manuscript.
Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations, appropriate institutional review board or ethics committee approval is required, and such approval should be stated in the methods section of the manuscript. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed (World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Available at: http://www.wma.net/en/30publications/10policies/b3/index.html).
For investigation of human subjects, state explicitly in the methods section of the manuscript that informed consent was obtained from all participating adult subjects and from parents or legal guardians for minors or incapacitated adults, together with the manner in which informed consent was obtained (i.e., oral or written).
For work involving experimental animals, the guidelines for their care and use should be in accordance with European Commission Directive 86/609/EEC for animal experiments (available at http://ec.europa.eu/environment/chemicals/ lab_animals/legislation_en.htm); this should be stated in the methods section of the manuscript.
Reporting Clinical Trials
All randomized controlled trials submitted for publication should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart (available at http://www.consort-statement.org). This Journal has adopted the proposal from the International Committee of Medical Journal Editors (ICMJE) that require, as a condition of consideration for publication of clinical trials, registration in a public trials registry. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) do not require registration. Further information can be found at http://www.icmje.org.
Identification of Patients in Descriptions, Photographs and Pedigrees
A signed statement of informed consent to publish (in print and online) patient descriptions, photographs and pedigrees should be obtained from all persons(parents or legal guardians for minors) who can be identified (including by the patients themselves) in such written descriptions, photographs or pedigrees. Such persons should be shown the manuscript before its submission. Omitting data or making data less specific to de-identify patients is acceptable, but changing any such data is not acceptable. State explicitly in the methods section of the manuscript that informed consent was obtained from all participating adult subjects or from parents or legal guardians for minors or incapacitated adults, together with the manner in which informed consent was obtained (i.e., oral or written).
Previous Publication or Duplicate Submission
Submitted manuscripts are considered with the understanding that they have not been published previously in print or electronic format (except in abstract or poster form) and are not under consideration in totality or in part by another publication or electronic medium.
Articles should be written in English (using American English spelling) and meet the following basic criteria: the material is original, the information is important, the writing is clear and concise, the study methods are appropriate, the data are valid, and the conclusions are reasonable and supported by the data.
Reviews of contemporary topics of regional interest may be submitted. These should aim to provide the reader with a balanced overview of an important and current subject in the field, and should be systematic and critical assessments of literature and data sources. They should cover aspects of a topic in which scientific consensus exists as well as aspects that remain controversial and are the subject of ongoing scientific research. All articles and data sources reviewed should include information about the specific type of study or analysis, population, intervention, exposure, and tests or outcomes. All articles or data sources should be selected systematically for inclusion in the review and critically evaluated. Personal views not based on documented evidence are discouraged. Typical length: Minimum 1500 words and maximum 3000 words, More than 20 references.
These may be randomized trials, intervention studies, studies of screening and diagnostic tests, laboratory and animal studies, cohort studies, cost-effectiveness analyses, case control studies, and surveys with high response rates, which represent new and significant contributions to the field.
Section headings should be: Abstract, Introduction, Methods, Results, Discussion, Conclusion, Acknowledgments (if applicable), Conflicts of Interest (if any), and References.
The Introduction should provide a brief background to the subject of the paper, explain the importance of the study, and state a precise study question or purpose.
The Methods section should describe the study design and methods (including the study setting and dates, patients/ participants with inclusion and exclusion criteria, or data sources and how these were selected for the study, patient samples or animal specimens used, explain the laboratory methods followed), and state the statistical procedures employed in the research.
The Results section should comprise the study results presented in a logical sequence, supplemented by tables and/or figures. Take care that the text does not repeat data that are presented in tables and/or figures. Only emphasize and summarize the essential features of any interventions, the main outcome measures, and the main results.
The Discussion section should be used to emphasize the new and important aspects of the study, placing the results in context with published literature, the implications of the findings, and the conclusions that follow from the study results. Hypotheses and impressions should be stated as such and only if supported by available facts. Patient groups and applicable conditions must be carefully defined whenever recommendations for treatment are made.
Typical length: Minimum 1500 words and maximum 4000 words, 15-80 references.
These are short discussions of a case or case series with unique features not previously described that make an important teaching point or scientific observation. They may describe novel techniques, novel use of equipment, or new information on diseases of importance. Section headings should be: Abstract, Introduction, Case Report, Discussion, Conclusion, Acknowledgments (if applicable), Conflicts of Interest (if any), and References.
The Introduction should describe the purpose of the present report, the significance of the disease and its specificity, and briefly review the relevant literature.
The Case Report should include the general data of the case, medical history, family history, chief complaint, present illness, clinical manifestation, methods of diagnosis and treatment, and outcome.
The Discussion should compare, analyze and discuss the similarities and differences between the reported case and similar cases reported in other published articles. The importance or specificity of the case should be restated when discussing the differential diagnoses. Suggest the prognosis of the disease and possibility of prevention. Typical length: Minimum 1000 words and maximum 3000 words, 20-30 references.
Letters to the Editor
These are short comments on previously published articles in the Journal; it must be accompanied by a Cover Letter. The text should not exceed 500 words with no more than 5 references. One table or one figure may be included. The Editors reserve the right to edit any letter received.
Title Page The title page should contain the following information (in order, from the top to bottom of the page):
- category of paper
- article title
- names (spelled out in full) of all authors*, and the institutions with which they are affiliated; indicate all affiliations with a superscripted lowercase letter after the author's name and in front of the appropriate affiliation
- declaration of any potential financial and non-financial conflicts of interest
- corresponding author details (name, e-mail, mailing address, telephone and fax numbers)
- running title not exceeding 50 characters
*The name of each author should be written with the family name last, e.g., Jing-Lin Chang. Authorship is restricted only to direct participants who have contributed significantly to the work.
Abstract and Keywords
Abstracts should be no more than 300 words in length. Abstracts for Original Articles should be structured, with the section headings: Background/Objective, Methods, Results, Conclusion. Abstracts for Case Reports are unstructured, but should include the significance and purpose of the case presentation, the diagnostic methods of the case, the key data, and brief comments and suggestions with regard to the case. Abstracts for Review Articles are also unstructured. For all article categories (except Letters to the Editor), 3-5 relevant keywords should be provided in alphabetical order. Keyowrds should be following Medical Subject Headings http://www.nlm.nih.gov/mesh/2014/mesh_browser/MBrowser.html
The text for Original Articles should be organized into sections as follows: Introduction, Methods, Results, Discussion. Sections for Case Reports are: Introduction, Case Report, Discussion. The text for Review Articles should be divided into logical sections with appropriate headings. Each section should begin on a new page.
Where a term/definition will be continually referred to, it must be written in full when it first appears in the text, followed by the subsequent abbreviation in parentheses. Thereafter, the abbreviation may be used. An abbreviation should not be first defined in any section heading; if an abbreviation has previously been defined in the text, then the abbreviation may be used in a subsequent section heading. Restrict the number of abbreviations to those that are absolutely necessary.
Numbers that begin a sentence or those that are less than 10 should be spelled out using letters. Centuries and decades should be spelled out, e.g., the Eighties or nineteenth century. Laboratory parameters, time, temperature, length, area, mass, and volume should be expressed using digits.
Système International (SI) units must be used, with the exception of blood pressure values which are to be reported in mmHg. Please use the metric system for the expression of length, area, mass, and volume. Temperatures are to be given in degrees Celsius.
Names of drugs, devices and other products
Use the Recommended International Non-proprietary Name (rINN) for medicinal substances, unless the specific trade name of a drug is directly relevant to the discussion. Generic drug names should appear in lowercase letters in the text. If a specific proprietary drug needs to be identified, the brand name may appear only once in the manuscript in parentheses following the generic name the first time the drug is mentioned in the text.
For devices and other products, the specific brand or trade name, the manufacturer and their location (city, state, country) should be provided the first time the device or product is mentioned in the text, for example, "?KIBM SPSS Statistics 21.0 was used (IBM Corp., Armonk, NY, USA)". Thereafter, the generic term (if appropriate) should be used.
Statistical analysis is essential for all research papers except case reports. Use correct nomenclature for statistical methods (e.g., two sample t test, not unpaired t test). Descriptive statistics should follow the scales used in data description. Inferential statistics are important for interpreting results and should be described in detail.
All p values should be expressed to 2 digits to the right of the decimal point, unless p< 0.01, in which case the p value should be expressed to 3 digits to the right of the decimal point. The smallest p value that should be expressed is p < 0.001, since additional zeros do not convey useful information; the largest p value that should be expressed is p> 0.99.
Personal communications and unpublished data
These sources cannot be included in the references list but may be described in the text. The author(s) must give the full name and highest academic degree of the person, the date of the communication, and indicate whether it was in oral or written (letter, fax, e-mail) form. A signed statement of permission should be included from each person identified as a source of information in a personal communication or as a source for unpublished data.
General acknowledgments for consultations and statistical analysises should be listed concisely at the end of the text, including the names of the individuals who were directly involved. Consent should be obtained from those individuals before their names are listed in this section.
All financial and material support for the research, work, writing and editorial assistance from internal or external agencies, including commercial companies, should be clearly and completely identified.
In the main text, tables, figure legends
- References should be identified using superscripted numbers, and numbered consecutively in order of appearance in the text; the numbers should be placed after periods and commas and before colons and semicolons.
- References cited in tables or figure legends should be included in sequence at the point where the table or figure is first mentioned in the main text.
- Do not cite uncompleted work or work that has not yet been accepted for publication (i.e., "unpublished observation", "personal communication") as references (also see Section 9.3.6.).
- Do not cite abstracts unless they are the only available reference to an important concept.
In the references list
- References should be limited to those cited in the text and listed in numerical order, NOT alphabetical order.
- References should include, in order, authors' surnames and initials, article title, abbreviated journal name, year, volume and inclusive page numbers. The last names and initials of all the authors up to 3 should be included, but when authors number 7 or more, list the first 3 authors only followed by "et al”.
- If citing a website, provide the author information, article title, website address and the date you accessed the information.
- Reference to an article that is in press must state the journal name and, if possible, the year and volume.
Authors are responsible for the accuracy and completeness of their references and for correct text citation.
Examples are given below.
Standard journal articles
Bisdas T, Pichlmaier M, Wilhelmi M, Bisdas S, Haverich A, Teebken O. Effects of the ABO-mismatch between donor and recipient of cryopreserved arterial homografts. IntAngiol 2011;30:247-255.
Quintini C, D'Amico G, Brown C, et al. Splenic artery embolization for the treatment of refractory ascites after liver transplantation. Liver Transpl 2011;17:668- 673.
Kaplan NM. The endothelium as prognostic factor and therapeutic target: what criteria should we apply? J CardiovascPharmacol 1998;32(suppl 3):S78-80.
Journal article not in English but with English abstract
Kawai H, Ishikawa T, Moroi J, et al. Elderly patient with cerebellar malignant astrocytoma. No ShinkeiGeka. 2008;36:799-805. [In Japanese, English abstract]
Bradley EL. Medical and Surgical Management. Philadelphia: Saunders; 1982:72-95.
Book chapter in book with editor and edition
Greaves M, Culligan DJ.Blood and bone marrow. In: Underwood JCE, ed. General and Systematic Pathology. 4th ed. London: Churchill Livingstone; 2004:615-672.
World Health Organization.World Health Report 2002: Reducing Risk, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002.
Conference proceedings Pacak K, Aguilera G, Sabban E, Kvetnansky R, eds. Stress: Current Neuroendocrine and Genetic Approaches.8th Symposium on Catecholamines and Other Neurotransmitters in Stress, June 28-July 3, 2003, Smolenice Castle, Slovakia. New York: New York Academy of Sciences; 2004.
Ayers AJ. Retention of Resin Restorations by Means of Enamel Etching and by Pins [MSD thesis]. Indianapolis, IN: Indiana University; 1971.
WebsiteWisdom Teeth.American Association of Oral and Maxillofacial Surgeons Web site. Error! Hyperlink reference not valid.. Accessed November 15, 2008.
Eastman Kodak Company, Eastman Organic Chemicals. Catalog No. 49. Rochester, NY: Eastman Kodak; 1977:2-3
Tables should supplement, not duplicate, the text. They should have a concise table heading, be self-explanatory, and numbered consecutively in the order of their citation in the text. Items requiring explanatory footnotes should be denoted using superscripted lowercase letters (a, b, c, etc.), with the footnotes arranged under the table in alphabetical order.
Figures should be added at the end of main text (i.e after references), the figures should not be edited (a high definition figure) should be added in the Word File. At the end of the figure, it should be labeled as Figure 1. (Description), along with that the figure should be cited in the text.
Unless authors have the written permission from the patient (or, where applicable, the next of kin), the personal details (such as their name and date of birth) of the patient must be removed. If their face is shown, use a black bar to cover their eyes so that they cannot be identified.
- JPEG, TIFF: Color or grayscale photographs (halftones): always use a minimum of 400 dpi.
- DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications, please supply "as is".
The Editorial and Peer Review Process
As a general rule, the receipt of a manuscript will be acknowledged within 2 weeks of submission, and authors will be provided with a manuscript reference number for future correspondence. If such an acknowledgment is not received in a reasonable period of time, the author should contact the Editorial Office.
Submissions are reviewed by the Editorial Office to ensure that it contains all parts and meet the quality of the Journal. The Editorial Office will not accept a submission if the author has not supplied all parts of the manuscript and supporting documents as outlined in these instructions.
Manuscripts are then forwarded to the Editor-in- Chief, who makes an initial assessment of it. If the manuscript does not appear to be of sufficient merit or is not appropriate for the Journal, then the manuscript will be rejected without review. Rejected manuscripts will not be returned to authors unless requested.
Manuscripts that appear meritorious and appropriate for the Journal are reviewed by at least two Editorial Board members or expert consultants assigned by the Editor-in-Chief.
Authors are usually notified within 2-4 weeks of whether the submitted article is accepted for publication, rejected, or subject to revision before acceptance. However, do note that delays are sometimes unavoidable.
If revisions are required, authors are asked to return a revised manuscript to the Editorial Office by e-mail to email@example.com / firstname.lastname@example.org in the same thread that the editors have requested for within 15 days. Please notify the Editorial Office in advance if additional time is needed or if you choose not to submit a revised manuscript.
When the author sends us the manuscripts initially, the journal team would send confirmation mail for payment. Once the authors agrees to pay the money, then only review process will be commenced. Upon acceptance of a manuscript for publication, acceptance letter will be forwarded to you. After that once the article is accepted and when the acceptance letter is sent to Authors, the authors cannot back out with their article. If author wants to withdraw the article after acceptance letter has been send the author has to pay the peer review charges. The peer review charges would be decided by Editorial team as it would differ with each article and reviewers. If the authors doesn't pay the peer review charges the authors article will be kept with journal database and it will be hence forth property of journal. Then authors would have no rights with that particular article and journal hold rights to take action against author or do anything with that article.
If the article is accepted, the copy of final layout is sent for proof reading to the corresponding author, that has to be returned within 5 days time with the changes required, please do note that no major changes would be made.
Changes to Authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts. Before the accepted manuscript is published online, requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include:
- the reason the name should be added or removed, or the author names rearranged; and
- Updated Authorship & Conflicts of Interest Statement with signatures from all authors that they agree with the addition, removal or rearrangement.
- In the case of addition or removal of author names, this must include confirmation from the author(s) being added or removed.
- Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedures as described above.
- Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) online publication of the accepted manuscript is suspended until authorship has been agreed.
- After the accepted manuscript is published online, any requests to add, remove, or rearrange author names in an article won’t be made.
Publication Charges and Reprints
Authors of accepted articles will be charged a publication fee. In the event that a manuscript is accepted, the corresponding author will be instructed by the Editorial Office on how to transmit their payment to the Journal. The accepted article will be processed to the next stage only upon receipt of payment.
Professional reprints (which include a cover page for the article) may be ordered from the Publisher at prices based on the cost of production that approximates to INR 800 (Subject to changes according the cost of printing and charges of mailing)
Manuscripts published in the IJSS Journal of Surgery become the permanent property of the Smile Nation, Lets Smile Together, Pune, India, and may not be published elsewhere in any form without written permission. All articles published in the Journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article, as well as translation rights. No part of this publication may be reproduced, stored in any retrieval system, or transmitted in any form or by any means, electronic, mechanical, by photocopying, recording, or otherwise, without prior written permission from the IJSS Journal of Surgery.
Affiliations For Conferences
Announcements of any surgical conferences and meetings are published free of charge. Please specify the title of the meeting, the dates and venue, organizers and secretariat address. Notices should be e-mailed to the Editorial Office at email@example.com / firstname.lastname@example.org Special Issues shall be launched on demand by the secretariat, to publish the conference abstracts and keynotes, the cost of designing and paper back shall be bared by the conference secretariat, IJSS Journal of Surgery shall make it available online and provide a web space.